Outcome of symptoms and acid exposure after endoscopic therapy in gastro-oesophageal reflux disease: summary of uncontrolled studies
Symptoms | pH <4%time | No of patients | |||
---|---|---|---|---|---|
Pre | Post | Pre | Post | ||
*Significant difference. | |||||
†QOLRAD score. | |||||
‡Per cent satisfaction. | |||||
Endocinch | |||||
Park et al26 | 5 | 1* | 8.5 | 3.7* | 142 |
Filipi et al21 | 62.7 | 17* | 9.6 | 8.5 | 64 |
Mahmood et al44 | 79 | 27* | 11.1 | 9.3* | 21 |
Arts et al27 | 11.6 | 7.1* | 17.0 | 9.8* | 20 |
Enteryx | |||||
Johnson et al20 | 25.5 | 8.5* | 9.0 | 6.4* | 85 |
Stretta | |||||
Triadafilopoulos et al22 | 27 | 9* | 10.2 | 6.4* | 94 |
DiBaise et al41 | 21.5 | 7* | 9.5 | 6.2* | 18 |
Tam et al40 | 19 | 6* | 10.6 | 6.3* | 15 |
Meier et al33 | 17 | 7* | 25 | ||
Houston et al32 | 3.7† | 5.1†* | 8.4 | 4.4* | 41 |
Wolfsen et al35 | 26% | 77%‡* | 558 |